Nektar Therapeutics reported $28.33M in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
ALKERMES ALKS:US $ 303.72M 52.29M
Amgen AMGN:US $ 6526M 625M
Astrazeneca AZN:US $ 8220M 900M
Baxter International BAX:US $ 3098M 152M
Biocryst Pharmaceuticals BCRX:US $ 49.96M 30.9M
Biogen BIIB:US $ 2778.9M 3.9M
Bluebird Bio BLUE:US $ 7.47M 5.32M
Bristol Myers Squibb BMY:US $ 11703M 630M
Cara Therapeutics CARA:US $ 0 1.93M
Dr.Reddys Laboratories DRRD:IN IR 49451M 1769M
Eisai 4523:JP Y 198894M 51284M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Esperion Therapeutics ESPR:US $ 40.66M 32.68M
Exelixis EXEL:US $ 385.18M 114.95M
Gilead Sciences GILD:US $ 6217M 206M
GlaxoSmithKline GSK:LN 8092M 674M
Halozyme Therapeutics HALO:US $ 136.46M 47.43M
Immunogen IMGN:US $ 16.95M 1.24M
IONIS PHARMACEUT IONS:US $ 125.75M 14.14M
Ironwood Pharmaceuticals IRWD:US $ 104.03M 15.19M
Karyopharm Therapeutics KPTI:US $ 22.6M 659K
Macrogenics MGNX:US $ 30.76M 13.88M
Merk MRK:US $ 11402M 678M
Mirati Therapeutics MRTX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 28.33M 4.68M
Neurocrine Biosciences NBIX:US $ 288.9M 52.3M
Novartis NOVN:VX SF 13294M 600M
Pfizer PFE:US $ 18977M 4395M
Sarepta Therapeutics SRPT:US $ 164.09M 17.16M
Seattle Genetics SGEN:US $ 388.48M 56.5M
Takeda 4502:JP Y 949603M 179329M
Teva Pharmaceutical TEVA:IT 3.91B 72M
Xencor XNCR:US $ 67.45M 33.48M
YTE INCY:US $ 705.71M 100.99M